Preliminary data suggest that CDC’s recommendation that all qualified persons 6 months and older receive a 2024–2025 COVID-19 vaccination was an effective move.
APhA staff
On February 4, 2025, FDA approved Onapgo (apomorphine hydrochloride), a wearable infusion device, available soon in the United States for adults with advanced Parkinson’s disease.
On January 6, 2025, FDA published new draft guidance aimed at helping improve the accuracy and performance of pulse oximeters.
While previously published findings pointed to a decline in adherence to cardiovascular drug regimens following community pharmacy closures, new research suggests a similar pattern with anticonvulsants.
How prevalent is iron deficiency among the American public? Authors of a recent study published in JAMA sought answers and discovered that absolute and functional iron deficiency affect a large proportion of American adults even in the absence of anemia, heart failure, chronic kidney disease, or a current pregnancy.